Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC
Supported by an independant educational grant from Gilead Sciences Inc.

Part 1: The Growing Burden of HCV Infection in the US

Dr. Mark Sulkowski and Dr. Kathleen Brady discuss the struggle between addiction and HCV. Appropriate treatment begins with screening and diagnosis, overcoming barriers to treatment and adherence, and collaboration between caregivers. And for the first time, experts in HCV confidently use the word “cure” to describe the achievable endpoint of treatment. Dr. Sulkowski begins by introducing a young woman named Theresa who struggled with addiction to opioids. Listen as they are joined by Dr. Alain Litwin, who describes barriers and the epidemiology of HCV infection in the US.

Post-Test

Part 2: Game Changing Treatments to Cure HCV

Dr. Mark Sulkowski and Dr. Kathleen Brady discuss the game-changing treatments that are now available to cure HCV, and strategies to apply these treatments in the addiction medicine setting. Listen as they are joined by Dr. Raymond Chung, who discusses guidelines and new combination regimens.

Post-Test

Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC

Supported by an independant educational grant from Gilead Sciences Inc.

Hepatitis C (HCV) is the most-deadly infectious disease in America.

  • More than 20,000 die every year because of HCV
  • Half of people infected do not know that they have the virus
  • HCV can remain undetected for decades

HCV is curable, even among past and current drug users. You can help turn the tide. Learn how to screen (hint: it's easy) and how screening can save lives.

Treatment is now simpler, more effective, and shorter than ever. And it should be offered to nearly everyone with HCV, regardless of the level of cirrhosis.

Tune in to START HCV Radio Hour to listen and learn as our expert faculty explore important topics, using patient stories in an engaging moderated DKBmed Talk, modeled after the famous and popular TED Talks.

  • Learn how to detect HCV infection with a simple blood test
  • Become familiar with revolutionary new treatment options that cure 99% of people who use them
  • Prevent the spread of HCV and the morbidity and mortality that can follow

The expert faculty includes Mark Sulkowski, MD, professor of medicine and medical director of the Viral Hepatitis Center at the Johns Hopkins University School of Medicine; Alain Litwin, MD, professor of medicine at Albert Einstein College of Medicine in New York; Kathleen Brady, MD, Distinguished University Professor at the Medical University of South Carolina and Director of the South Carolina Clinical and Translational Research Institute; and Raymond Chung, MD, director of hepatology and the Liver Center at Massachusetts General Hospital in Boston.

Start Program

Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC
Supported by an independant educational grant from Gilead Sciences Inc.

Program Directors

Mark S. Sulkowski, MD

Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
Johns Hopkins University School of Medicine
Baltimore, Maryland


Kathleen T. Brady, MD, PhD

Distinguished University Professor
Vice President for Research
Director, South Carolina Clinical and Translational Research Institute
Medical University of South Carolina
Charleston, South Carolina

Faculty

Alain H. Litwin, MD

Professor, Department of Medicine (General Internal Medicine)
Department of Psychiatry and Behavioral Sciences
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY


Raymond T. Chung, MD

Director of Hepatology and Liver Center
Vice Chief, Gastroenterology
Kevin and Polly Maroni Research Scholar
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts

Jointly Provided by Postgraduate Institute for Medicine and DKBmed, LLC
Supported by an independant educational grant from Gilead Sciences Inc.

CME/CE

Accreditation Information

Target Audience

This activity has been designed to meet the educational needs of clinicians interested in addiction medicine.

Physician Continuing Medical Education

Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and DKBmed. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
The Postgraduate Institute for Medicine designates these enduring activities for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Social Worker Credit Designation

Part 1: This program was approved for .5 General contact hour(s) of continuing education credit by the National Association of Social Workers—Louisiana Chapter as authorized by the Louisiana State Board of Social Work Examiners.

Part 2: This program was approved for .5 General contact hour(s) of continuing education credit by the National Association of Social Workers—Louisiana Chapter as authorized by the Louisiana State Board of Social Work Examiners.

Estimated time to complete each activity: 0.5 hours (1.0 hours total)

Educational Objectives

After completing this activity, the participant should be better able to:

    Part 1:
  • Describe recent expansions of the US Preventive Services Task Force screening recommendations and the importance of identifying patients who may be at risk.
  • Identify and utilize newer, less invasive HCV screening options.
  • Distinguish between actual and perceived barriers and develop comprehensive plans to overcome these barriers in PWID.
    Part 2:
  • Describe the importance of early treatment, the safety and efficacy of new DAAs, and the role these therapies play in preventing cirrhosis and HCC.
  • Identify people who are eligible for treatment for HCV.
  • Identify the barriers to adherence and develop plans to overcome these barriers.

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

Faculty / Presenter Reported Financial Relationship

    Mark S. Sulkowski, MD
  • Consulting Fees: AbbVie, Inc., Cocrystal Pharma, Inc., Gilead Sciences, Inc., Merck & Co., Inc., Janssen, Trek
  • Contracted Research: AbbVie, Inc., Gilead Sciences, Inc., Merck & Co., Inc. (funds paid to Johns Hopkins)
    Kathleen T. Brady, MD, PhD
  • None
    Alain H. Litwin, MD
  • Consulting Fees: AbbVie, Inc., Gilead Sciences, Inc., Merck & Co, Inc.
  • Contracted Research: Gilead Sciences, Inc., Merck & Co., Inc.
    Raymond T. Chung, MD
  • Contracted Research: AbbVie, Inc., Boehringer Ingelheim, Gilead Sciences, Inc., Janssen

The planners and managers reported the following financial relationships or relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity:

The following PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, RN, BSN and Jan Schultz, RN, MSN, CHCP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following DKB planners and managers Stan Pogroszewski, and Rachel Deerr hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Method of Participation and Request for Credit

There are no fees for participation in this CME activity. To receive credit, participants must 1) read the learning objectives and disclosure statements, 2) complete the educational activity and 3) complete the post-test and activity evaluation form, including the certificate information section. Physicians and social workers must attest to the amount of time they spent on the activity.

Enduring Materials

  • Physician (CME) Release Date: 12/21/17
  • Physician (CME) Expiration date: 12/20/19
  • Social Worker Release Date: 2/1/18
  • Social Worker Expiration Date: 2/1/19

Hardware & Software Requirements

PC: Internet Explorer (v9 or greater), Chrome or Firefox
MAC: Safari
Monitor settings: High color at 800 x 600 pixels, Sound card and speakers, Adobe Acrobat Reader.

Copyright © 2017. PIM and START: HCV
Presented by PIM in collaboration with DKBmed